PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 95 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,977,716 | -27.0% | 894,894 | -16.1% | 0.00% | – |
Q1 2023 | $2,710,207 | +22.9% | 1,067,011 | -9.5% | 0.00% | – |
Q4 2022 | $2,204,339 | -28.7% | 1,178,791 | -2.0% | 0.00% | – |
Q3 2022 | $3,092,000 | +84.3% | 1,203,446 | +38.5% | 0.00% | – |
Q2 2022 | $1,678,000 | -80.8% | 869,224 | -70.4% | 0.00% | – |
Q1 2022 | $8,734,000 | -34.7% | 2,940,513 | -1.2% | 0.00% | – |
Q4 2021 | $13,370,000 | -5.7% | 2,977,680 | +2.1% | 0.00% | – |
Q3 2021 | $14,177,000 | -28.3% | 2,917,140 | +0.7% | 0.00% | -100.0% |
Q2 2021 | $19,759,000 | -19.5% | 2,897,320 | -16.7% | 0.00% | 0.0% |
Q1 2021 | $24,557,000 | +13.8% | 3,478,440 | +0.9% | 0.00% | 0.0% |
Q4 2020 | $21,580,000 | +31.6% | 3,447,329 | +13.7% | 0.00% | 0.0% |
Q3 2020 | $16,398,000 | +13.7% | 3,030,848 | +9.7% | 0.00% | 0.0% |
Q2 2020 | $14,416,000 | +90.0% | 2,761,736 | +14.6% | 0.00% | – |
Q1 2020 | $7,588,000 | -19.0% | 2,408,849 | +3.7% | 0.00% | – |
Q4 2019 | $9,366,000 | -18.1% | 2,323,912 | -12.2% | 0.00% | – |
Q3 2019 | $11,436,000 | +12.2% | 2,646,900 | +3.6% | 0.00% | – |
Q2 2019 | $10,193,000 | -27.1% | 2,554,792 | -2.0% | 0.00% | -100.0% |
Q1 2019 | $13,977,000 | +1.8% | 2,607,486 | -2.6% | 0.00% | 0.0% |
Q4 2018 | $13,729,000 | -47.1% | 2,676,432 | -0.0% | 0.00% | 0.0% |
Q3 2018 | $25,967,000 | -1.5% | 2,677,154 | +3.6% | 0.00% | 0.0% |
Q2 2018 | $26,350,000 | -0.1% | 2,583,390 | +27.3% | 0.00% | 0.0% |
Q1 2018 | $26,374,000 | -22.6% | 2,028,845 | +6.6% | 0.00% | -50.0% |
Q4 2017 | $34,075,000 | -29.6% | 1,903,651 | -1.4% | 0.00% | 0.0% |
Q3 2017 | $48,436,000 | +6.2% | 1,929,713 | +2.0% | 0.00% | 0.0% |
Q2 2017 | $45,608,000 | +57.5% | 1,892,447 | +25.8% | 0.00% | 0.0% |
Q1 2017 | $28,950,000 | +93287.1% | 1,503,842 | +73008.5% | 0.00% | – |
Q4 2016 | $31,000 | +72.2% | 2,057 | +49.7% | 0.00% | – |
Q3 2016 | $18,000 | -5.3% | 1,374 | 0.0% | 0.00% | – |
Q2 2016 | $19,000 | +72.7% | 1,374 | +89.8% | 0.00% | – |
Q1 2016 | $11,000 | +83.3% | 724 | +149.7% | 0.00% | – |
Q4 2015 | $6,000 | 0.0% | 290 | 0.0% | 0.00% | – |
Q3 2015 | $6,000 | -14.3% | 290 | 0.0% | 0.00% | – |
Q2 2015 | $7,000 | – | 290 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 1,609,398 | $7,821,000 | 1.64% |
Telemetry Investments, L.L.C. | 242,514 | $1,179,000 | 1.59% |
Omega Fund Management, LLC | 2,606,809 | $12,669,000 | 1.42% |
Bruce & Co., Inc. | 1,343,312 | $6,528,000 | 1.39% |
1492 Capital Management LLC | 488,309 | $2,373,000 | 1.20% |
Abingworth LLP | 1,041,131 | $5,060,000 | 1.15% |
Trellus Management Company, LLC | 295,000 | $1,434,000 | 1.04% |
Worth Venture Partners, LLC | 389,440 | $1,893,000 | 0.85% |
CM Management, LLC | 200,000 | $972,000 | 0.72% |
GENERAL AMERICAN INVESTORS CO INC | 1,112,658 | $5,408,000 | 0.46% |